Lab
Prenatal Lab
search
Prenatal Lab
, Antepartum Laboratory Testing
Labs
Initial - All Patients
Complete Blood Count
Hemoglobin
Platelet
s
Urine sample
Urine Culture
Urinalysis
Asymptomatic Bacteriuria
complicates 15% of pregnancies (
Pyelonephritis
develops in 30% of cases)
Blood Type
ABO and Rh
Antibody
screen (
Coombs
test)
Rubella
Antibody
MMR contraindicated during pregnancy
Administer postpartum MMR if negative
Screen prior to pregnancy and immunize if negative
Syphilis Serology
Universal, first trimester
Syphilis Screening
recommended with automated
Treponema
l test
Repeat testing at 28 weeks if at risk (e.g. STI history, exposures or high
Prevalence
region)
Primary and secondary maternal
Syphilis
as well as
Congenital Syphilis
has increased significantly since 2015
Untreated
Syphilis
is associated with adverse outcomes in up to 80% of affected pregnancies
Tsai (2019) Obstet Gynecol Surv 74(9): 557-64 [PubMed]
Half of patients asympomatic and without significant known risk factors
Triveldi (2019) Obstet Gynecol 133(1): 27-32 [PubMed]
Hepatitis B Surface Antigen
(
HBsAg
)
Universal screening recommended in U.S.
If at risk,
Hepatitis B Vaccine
(safe in pregnancy)
Hepatitis C Antibody
ACOG recommends screening as part of Prenatal Labs
HIV Test
Universal screening recommended
Consider
HIV PrEP
in patients at higher risk of STI
HIV risk increases before, during and after pregnancy, esp. with history of
Bacteria
l STI
HIV PrEP
with
Truvada
is considered safe in pregnancy (not in
Lactation
)
Pelvic Exam Initial Labs
Pap Smear
Gonorrhea
PCR and
Chlamydia PCR
Universal screening recommended
Thyroid Stimulating Hormone
(TSH, with reflex
Free T4
)
See
Pregnancy Risk Assessment
regarding
Thyroid
disease risk in pregnancy
See
Thyroid Dysfunction in Pregnancy
HIstorically has been a part of routine pregnancy labs in U.S.
However no evidence that universal screening improves pregnancy outcomes
Obtain if history of
Thyroid
disease or as clinical findings dictate
References
(2020) Obstet Gynecol 135(6):e261-74 +PMID: 32443080 [PubMed]
Labs
Initial - Specific Risk Factor Directed Tests
Vaginitis
testing if symptomatic
Bacterial Vaginosis
Trichomonas
Genital Herpes
Chlamydia
and
Gonorrhea
PCR
Indicated in maternal age <25 years or
Sexually Transmitted Infection
risk factors
Repeat testing in third trimester if at risk
Group B Streptococcus Culture
Culture both vagina and anus
Sickle Cell Anemia
or
Sickle Cell Trait
screen
Predisposes to
Pyelonephritis
Glucose Challenge Test
(50 g Glucola drink)
If no maternal history of Varicella infection
Obtain varicella zoster IgG and if negative
Avoid Varicella exposure
If exposed, consider varicella
Immunoglobulin
Offer postpartum
Varicella Vaccine
Wait 3 months after last
RhoGAM
shot
Varicella Vaccine
is contraindicated in pregnancy
Screen prior to pregnancy and immunize if negative
Labs
Second Trimester (16-18 weeks)
See
Triple Analyte Screen
Consider first trimester screening of trisomy 16, 18
Urine Culture
Labs
Early Third Trimester (26-28 weeks)
Glucose Challenge Test
(50 g Glucola drink)
Hemoglobin
If
Rh Negative
mother
Repeat
Antibody
screen (
Coombs
test)
Administer
RhoGAM
300 mcg after blood draw
If mother at risk for
Sexually Transmitted Disease
(e.g. age <25 years, incarceration, multiple sex partners,
Illicit Drug
use)
Repeat RPR for
Syphilis Testing
Repeat
Gonorrhea
PCR and
Chlamydia PCR
Repeat
Hepatitis B Surface Antigen
(
HBsAg
)
Repeat
HIV Test
If high risk for
Preterm Labor
Consider
Bacterial Vaginosis
screening
Consider
Fetal Fibronectin
Labs
Late Third Trimester (35-37 weeks)
Group B Streptococcus
screening
References
Reese (2024) Am Fam Physician 109(1): 10-12 [PubMed]
Type your search phrase here